Now you can prevent the risk of cancer by vaccination against Human Papilloma virus (HPV)

It has now been established that almost all cancers of the cervix are caused by a virus called the Human Papilloma virus (HPV). There are only a handful of strains of these viruses that can cause cancer. There are only two licensed new HPV vaccines. Gardasil (Sanofi Pasteur MSD) prevents infection from 4 strains that cause over 70% of cervical cancers and 90% of genital warts. Cervarix (GSK) is especially constituted with a carrier molecule for longer lasting immunity.

Cervarix HPV Vaccine protects against type 16 & 18
Gardasil HPV vaccine provides 100% protection against 4 type 6, 11, 16 and 18.

The Cervarix vaccine has been selected to be used in the prevention of cervical cancer in women in the UK.

The programme of vaccination, starting with young girls aged 13 started in September 08 with a massive nationwide campaign. The latest announcement has set to include girls aged 17-18 in the programme, which is very good news. It is not clear when or whether other age groups will be offered vaccination. It is therefore up to individuals and their families to decide on this important.

Cervarix HPV Vaccine protects against type 16 & 18 which are responsible for around 75% of cervical cancers. There is mounting evidence that Cervarix offers higher and longer sustained protection; a fact that may have played a role in the UK Government’s decision to award the contract to GSK, manufacturers of Cervarix. Gardasil HPV vaccine provides protection against 4 types: 6 & 11 (causing genital warts) , 16 and 18 which cause cervical cancer.

Recommended Immunisation Schedule:

Each individual should have three (3) vaccine injections at month 0, month 2 and 6 month. Each injection is £150.00, making a total of £450 for the full course.